VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+12.8%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$237M
AUM Growth
-$4.18M
(-1.7%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-6.66%
Top 10 Holdings %
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61
Top Buys
| 1 |
EOG Resources
EOG
|
+$2.02M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.99M |
| 3 |
ConocoPhillips
COP
|
+$1.85M |
| 4 |
Imperial Oil
IMO
|
+$1.8M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$1.76M |
Top Sells
| 1 |
Ryman Hospitality Properties
RHP
|
+$2.57M |
| 2 |
Western Midstream Partners
WES
|
+$2.52M |
| 3 |
INN
Summit Hotel Properties
INN
|
+$2.43M |
| 4 |
Brookfield Renewable
BEPC
|
+$2.38M |
| 5 |
Grupo Aeroportuario del Pacifico
PAC
|
+$2.16M |
Sector Composition
| 1 | Healthcare | 30.46% |
| 2 | Real Estate | 18.03% |
| 3 | Energy | 13.68% |
| 4 | Materials | 11.34% |
| 5 | Utilities | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
BlackRock Limited Duration Income Trust
BLW
$550M
| $323K | 0.14% |
19,264
+3,424
| +22% | +$57.4K |
|
227
CEL-SCI Corp
CVM
$71.2M
| $323K | 0.14% |
707
+12
| +2% | +$5.48K |
|
228
Akebia Therapeutics
AKBA
$830M
| $320K | 0.14% |
94,432
+1,661
| +2% | +$5.63K |
|
229
Revolution Medicines
RVMD
$7.68B
| $318K | 0.13% |
6,925
+120
| +2% | +$5.51K |
|
230
Scholar Rock
SRRK
$3.04B
| $317K | 0.13% |
6,257
+103
| +2% | +$5.22K |
|
|
NGM
231
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $316K | 0.13% |
10,874
+189
| +2% | +$5.49K |
|
232
BlackRock Floating Rate Income Trust
BGT
$317M
| $315K | 0.13% |
25,200
+3,745
| +17% | +$46.8K |
|
233
Rigel Pharmaceuticals
RIGL
$733M
| $315K | 0.13% |
9,197
+161
| +2% | +$5.51K |
|
234
Relmada Therapeutics
RLMD
$53.1M
| $315K | 0.13% |
8,947
+164
| +2% | +$5.77K |
|
235
Sutro Biopharma
STRO
$83.3M
| $314K | 0.13% |
13,812
+236
| +2% | +$5.37K |
|
|
DRNA
236
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $311K | 0.13% |
12,152
+213
| +2% | +$5.45K |
|
237
Acadia Pharmaceuticals
ACAD
$4.28B
| $310K | 0.13% |
12,004
+329
| +3% | +$8.5K |
|
238
Akero Therapeutics
AKRO
$3.57B
| $303K | 0.13% |
10,454
+178
| +2% | +$5.16K |
|
239
Invesco Senior Income Trust
VVR
$552M
| $303K | 0.13% |
72,233
+7,406
| +11% | +$31.1K |
|
240
BridgeBio Pharma
BBIO
$10.4B
| $302K | 0.13% |
4,902
+82
| +2% | +$5.05K |
|
241
Arcutis Biotherapeutics
ARQT
$2.08B
| $298K | 0.13% |
10,302
+185
| +2% | +$5.35K |
|
|
ARNA
242
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $297K | 0.13% |
4,273
+71
| +2% | +$4.94K |
|
|
SWTX
243
DELISTED
SpringWorks Therapeutics
SWTX
| $295K | 0.12% |
4,006
+66
| +2% | +$4.86K |
|
244
CytomX Therapeutics
CTMX
$360M
| $294K | 0.12% |
38,021
+678
| +2% | +$5.24K |
|
245
Legend Biotech
LEGN
$6.39B
| $291K | 0.12% |
10,016
+182
| +2% | +$5.29K |
|
246
Madrigal Pharmaceuticals
MDGL
$10.1B
| $290K | 0.12% |
2,480
+36
| +1% | +$4.21K |
|
247
Ardelyx
ARDX
$1.59B
| $289K | 0.12% |
43,649
+769
| +2% | +$5.09K |
|
248
Sangamo Therapeutics
SGMO
$158M
| $288K | 0.12% |
22,950
+396
| +2% | +$4.97K |
|
|
ALLK
249
DELISTED
Allakos
ALLK
| $285K | 0.12% |
2,480
+38
| +2% | +$4.37K |
|
250
Kiniksa Pharmaceuticals
KNSA
$2.71B
| $285K | 0.12% |
15,414
+266
| +2% | +$4.92K |
|